Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119203

Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.

P L Tran, J Weinbach, P Opolon, G Linares-Cruz, J P Reynes, A Grégoire, E Kremer, H Durand, and M Perricaudet

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Tran, P. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Weinbach, J. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Opolon, P. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Linares-Cruz, G. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Reynes, J. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Grégoire, A. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Kremer, E. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Durand, H. in: JCI | PubMed | Google Scholar

UA1301-CNRS, Institut Gustave Roussy, Villejuif, France. pl.tran@necker.fr

Find articles by Perricaudet, M. in: JCI | PubMed | Google Scholar

Published February 15, 1997 - More info

Published in Volume 99, Issue 4 on February 15, 1997
J Clin Invest. 1997;99(4):608–617. https://doi.org/10.1172/JCI119203.
© 1997 The American Society for Clinical Investigation
Published February 15, 1997 - Version history
View PDF
Abstract

A serious limitation in the use of the DNA-cleaving, antitumoral-antibiotic, bleomycin during chemotherapy is pulmonary toxicity. Lung injury induced by bleomycin is characterized by an increased deposition of interstitial extracellular matrix proteins in the alveolar wall that compromises respiratory function. Several drugs have been tested in animal models to prevent the pulmonary toxicity of bleomycin, but have not led to a useful clinical treatment because of their adverse effects on other tissues. We have shown that transgenic mice expressing Streptoalloteichus hindustanus (Sh) ble bleomycin resistance protein in pulmonary epithelial cells in the lungs are protected against bleomycin-induced toxicity in lungs. In the present study, we used intranasal administration by adenovirus-mediated gene transfer of the bleomycin resistance Sh ble gene to mouse lung for prevention of bleomycin-induced pulmonary fibrosis. We constructed recombinant adenoviruses Ad.CMVble and Ad.RSVble harboring the bleomycin resistance Sh ble gene under the control of the cytomegalovirus early promoter and the Rous sarcoma virus early promoter, respectively. Transgene expression was detected in epithelia of conducting airways and alveolar septa by immunostaining with a rabbit polyclonal antibody directed against the bleomycin resistance protein and persisted for the duration of drug treatment; i.e., up to 17 d. No toxic effect was seen in adenovirus-treated mice. Pretreatment of mice with Ad.CMVble or Ad.RSVble completely prevented collagen deposition 42-133 d after bleomycin treatment, as measured by lung OH-proline content. Histologic studies indicated that there was little or no lung injury in the adenovirus/bleomycin-treated mice compared with the bleomycin-treated mice. These observations may lead to new approaches for the prevention of bleomycin-induced pulmonary fibrosis.

Version history
  • Version 1 (February 15, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts